Related Experiment Video
Updated: May 10, 2026

11:14
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Bioinformatics methods for the analysis of hepatitis viruses
Francesco Moriconi1, Michael R Beard, Lilly Kw Yuen
1Hepatology Unit, University Hospital of Pisa, University of Pisa, Pisa, Italy.
Antiviral Therapy
|June 25, 2013
Summary
Bioinformatics databases offer new tools for studying chronic hepatitis B (HBV) and hepatitis C (HCV) infections. Integrating clinical and sequence data in these databases can advance research and treatment strategies for millions affected globally.
Area of Science:
- Virology
- Bioinformatics
- Hepatology
Background:
- Hepatotropic viruses Hepatitis B (HBV) and Hepatitis C (HCV) cause chronic infections in over 500 million people worldwide.
- Chronic HBV and HCV infections elevate the risk of severe liver complications, including cirrhosis and hepatocellular carcinoma.
- Recent advancements include immune-modulatory drugs and nucleoside/nucleotide analogues for treating HBV and HCV.
Purpose of the Study:
- To review public bioinformatics databases developed for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) research.
- To highlight the integration of bioinformatics tools within these specialized databases for viral genome analysis and drug resistance prediction.
Main Methods:
- Overview of publicly available bioinformatics tools for viral sequence analysis (e.g., ORF identification, gene prediction, homology searching, alignment, motif/epitope recognition).
- Review of specialized database systems designed for HBV and HCV research, focusing on their functionalities and data types.
Main Results:
- Development of public databases specifically for HBV and HCV research, offering tools for genome analysis and drug resistance prediction.
- These databases serve as repositories for viral sequences and provide integrated bioinformatics functionalities.
Conclusions:
- Public databases integrating bioinformatics tools have significant potential to advance hepatitis research and treatment strategies.
- The full impact relies on comprehensive data collection, including molecular sequences and anonymized patient clinical/treatment data.
Related Concept Videos
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...

